MOMA Therapeutics’ $150 Million Series B Financing

Martina Bellini North America Legal Chronicle
Tagged:

Goodwin Procter advised MOMA Therapeutics on the deal.MOMA Therapeutics announced its completion of a $150 million Series B Financing. MOMA Therapeutics is a biopharmaceutical company discovering…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here